Clinical utility of Metagenomic Next-Generation Sequencing on bronchoalveolar lavage fluid in diagnosis of Lower Respiratory Tract Infections

Author:

Zheng Yanfen1,Shi Yu1,Xiao Tongyang1,Liu Yan1,Jiang Guanmin1

Affiliation:

1. The Fifth Affiliated Hospital of Sun Yat-sen University

Abstract

Abstract Introduction: In this study, we aimed to evaluate the clinical utility of Metagenomic Next-Generation sequencing (mNGS) on bronchoalveolar lavage fluid (BALF) in diagnosis of Lower Respiratory Tract Infection (LRTIs). Methods: This retrospective study included 186 hospitalized patients with suspected LRTIs who visit The Fifth Affiliated Hospital of Sun Yat-Sen University from March 2023 to August 2023. Among them, each patient had undergone mNGS (DNA) testing; 155 patients had undergone both conventional culture and mNGS (DNA) testing. The detecting rate of mNGS was compared to the paired culture testing. The diagnostic efficacy was evaluated between mNGS and conventional culture. Results: The positive detection rates of pathogens between mNGS and conventional culture were significant different (81.29% vs 39.35%, P<0.05). The detection rate was still significantly different (70.32% VS 39.35%, P <0.05) with regard to bacteria and fungi detection. The sensitivity of mNGS in diagnosis of LRTIs was much higher than that of conventional culture (88.41% vs 43.48%; P <0.05), the specificity was opposite (76.47% vs 94.12%; P >0.05). Among 155 patients with paired conventional culture result, 77.54% and 35.51% of cases were detected as definite or probable pathogens by mNGS and culture respectively. Importantly, mNGS directly led to a change of treatment regimen in 58 (37.42%) cases, including antibiotic adjustment (29.68%) and ruling out active infection (7.74%). Moreover, treatment regimen remained unchanged in 97 (62.58%) cases as the current antibiotic therapy already covered the detected pathogens (36.13%) or empirical treatment was effective (11.68%). Conclusion: mNGS can identify a wide range of pathogens in LRTIs, with improved sensitivity and being more superior at diagnosing LRTIs etiologically. mNGS has the potential to enhance clinical outcomes by optimizing the treatment regimens.

Publisher

Research Square Platform LLC

Reference24 articles.

1. Torres, A., et al., Pneumonia. Nature reviews. Disease primers, 2021. 7(1): p. 25.

2. Community-Acquired Pneumonia;File T;The New England journal of medicine,2023

3. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Infectious diseases, 2018. 18(11): p. 1191–1210.

4. The pathology of pulmonary bacterial infection;Kradin R;Seminars in diagnostic pathology,2017

5. Adult bacterial meningitis: earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture;Glimåker M;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3